Skip to main content
Equibles

UBS Group AG

Position in HCWB — HCW Biologics Inc.

CIK 1610520 ZURICH, V8
Back to HCWB Full portfolio

Position in HCWB

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$4
-$3,314 QoQ
Shares Held
1
-99.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 12 holders
Holding Since
Sep 2021
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in HCWB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,672,124 across 561 Biotechnology names. HCWB ranks #547 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 5,450,825 $1,020,369,609
2 ROIV
Roivant Sciences Ltd.
 17,466,641 $618,144,423
3 PTGX
Protagonist Therapeutics, Inc
 3,399,221 $416,676,508
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 712,259 $353,800,411
5 MRNA
Moderna, Inc.
 4,463,211 $312,558,664
6 INSM
INSMED Inc
 2,584,446 $275,553,630
7 ABVX
Abivax S.A.
 1,844,918 $245,853,771
8 MDGL
Madrigal Pharmaceuticals, Inc.
 401,708 $215,697,109

All Filings in HCWB

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4 1
2026-03-31 $3,318 9,221
2025-12-31 $1,688 1,739
2025-06-30 $37,738 9,518
2024-09-30 $2,603 4,831
2024-06-30 $2,772 4,285
2024-03-31 $1,058 605
2023-12-31 $777 635
2023-09-30 $402 212
2023-03-31 $22 16
2022-12-31 $729 381
2022-06-30 $4,523 2,056
2022-03-31 $4,654 1,705
2021-09-30 $119,254 37,384